IMMUCELL CORPORATION -

ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021

09 Nov 2021 15:02:49 By Nasdaq GlobeNewswire

ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021

06 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team

14 Sep 2021 05:30:00 By Nasdaq GlobeNewswire

ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®

24 Aug 2021 05:30:00 By Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021

12 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021

05 Aug 2021 05:30:00 By Nasdaq GlobeNewswire

ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

07 Jul 2021 06:00:01 By Nasdaq GlobeNewswire

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

19 May 2021 11:00:00 By Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021

13 May 2021 15:05:02 By Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021

06 May 2021 12:41:06 By Nasdaq GlobeNewswire

ImmuCell Closes $4,250,000 Equity Financing

14 Apr 2021 16:15:42 By Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021

07 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020

22 Feb 2021 15:03:48 By Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020

16 Feb 2021 12:42:05 By Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020

07 Jan 2021 07:00:00 By Nasdaq GlobeNewswire